SciY has announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into its Laboratory Digitalization Suite, creating a unified vendor-agnostic platform that connects molecular research, quality control laboratories, and full-scale biopharma and specialty chemicals manufacturing environments through advanced automation capabilities.
Chinese researchers have developed AiCE, an artificial intelligence-informed approach that dramatically enhances protein engineering efficiency. The method integrates structural and evolutionary constraints into existing AI models, achieving 36-90% improvements in predictive accuracy whilst eliminating the need for specialised model training.
Japanese analytical technology leader HORIBA has launched a comprehensive scientific collaboration facility in Nuneaton, expanding UK access to advanced measurement technologies for biopharmaceuticals, diagnostics, and clean energy research. The 290m² facility strengthens the company’s global network of customer-focused analytical centres.
The collaboration combines GenNext’s AutoFox protein footprinting technology with Thermo Fisher’s mass spectrometry solutions to create an integrated workflow for biotherapeutic development, offering researchers enhanced capabilities for validating AI-generated protein structural models whilst streamlining complex analytical processes.
German protein technology specialist Cube Biotech has announced a significant leadership transition, appointing Michael Bencak as Chief Executive Officer whilst founder Didier Dargent assumes the Executive Chairman position. The strategic move positions the company for accelerated global expansion in drug discovery technologies.
Austrian biotech HeartBeat.bio has partnered with German AI company biotx.ai to identify and validate novel therapeutic targets for heart failure treatment. The collaboration integrates biotx.ai’s genome-wide causal mapping platform with HeartBeat.bio’s human cardiac organoid technology, aiming to accelerate precision medicine development for the 30 million patients affected globally.
BioMed X and Servier have established the first XSeed Labs facility in Europe at the Spartners incubator in Paris-Saclay. The collaboration will develop an AI-empowered platform for sterically guided design of bispecific antibodies, addressing critical constraints in cancer immunotherapy development.
EUROIMMUN (part of Revvity) has added 23 new assays to its portfolio of indirect immunofluorescence assays (IFA) for use on the UNIQO 160, its all-in-one instrument for walkway IFA automation. The new assays extend existing panels for autoantibody diagnostics in rheumatology, vasculitis, hepatology and gastroenterology.
Iron deficiency and iron deficiency anemia are remarkably common worldwide. However, recommended ferritin cut-off concentrations can vary widely and there is room for improvement in standardization across different assay platforms. Dr Katie Troike and Dr Adam McShane (Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA) recently conducted their own re-evaluation of ferritin […]
High performance solution for advanced urine determination
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.